Two Sigma Advisers
MRNS

Two Sigma Advisers’s Marinus Pharmaceuticals, Inc MRNS Stock Holding History

Two Sigma Advisers’s Portfolio MRNS Stock Details MRNS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-19,725
Closed -$34.7K – 2595
2024
Q3 		$34.7K Sell
19,725
-22,900
-54% -$32K ﹤0.01% 2233
2024
Q2 		$49.9K Sell
42,625
-100
-0.2% -$250 ﹤0.01% 2366
2024
Q1 		$386K Buy
+42,725
New +$415K ﹤0.01% 1973
2023
Q4 		– Sell
-19,725
Closed -$159K – 2679
2023
Q3 		$159K Sell
19,725
-54,300
-73% -$452K ﹤0.01% 2139
2023
Q2 		$804K Buy
+74,025
New +$634K ﹤0.01% 1617
2021
Q4 		– Sell
-18,175
Closed -$207K – 2846
2021
Q3 		$207K Sell
18,175
-64,850
-78% -$892K ﹤0.01% 2239
2021
Q2 		$1.49M Sell
83,025
-31,625
-28% -$509K ﹤0.01% 1445
2021
Q1 		$1.77M Buy
114,650
+18,202
+19% +$263K ﹤0.01% 1324
2020
Q4 		$1.18M Sell
96,448
-9,800
-9% -$137K ﹤0.01% 1487
2020
Q3 		$1.36M Buy
106,248
+74,323
+233% +$641K ﹤0.01% 1359
2020
Q2 		$324K Buy
31,925
+28,875
+947% +$266K ﹤0.01% 2093
2020
Q1 		$25K Buy
3,050
+250
+9% +$2.17K ﹤0.01% 2407
2019
Q4 		$24K Sell
2,800
-575
-17% -$3.23K ﹤0.01% 2320
2019
Q3 		$21K Sell
3,375
-8,600
-72% -$69.5K ﹤0.01% 2184
2019
Q2 		$199K Sell
11,975
-1,400
-10% -$24.3K ﹤0.01% 2133
2019
Q1 		$224K Buy
13,375
+700
+6% +$10.1K ﹤0.01% 2087
2018
Q4 		$146K Buy
+12,675
New +$256K ﹤0.01% 2183

Other funds holding MRNS

BCM
Beryl Capital Management Redondo Beach, California $110M AUM 317.92% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
OBAM
ODDO BHF Asset Management Paris, France $2.54B AUM 41.83% 1-Year Est. Return
BCLSI
Bain Capital Life Sciences Investors Boston, Massachusetts $1.11B AUM 171.34% 1-Year Est. Return
Aberdeen Group
Aberdeen Group Edinburgh, United Kingdom $61.9B AUM 29.81% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
WP
Woodline Partners San Francisco, California $26.4B AUM 44.85% 1-Year Est. Return
GCP
GSA Capital Partners London, United Kingdom $1.61B AUM 28.28% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Two Sigma Advisers's MRNS Position: Q4 2024 in Review

Two Sigma Advisers sold out of Marinus Pharmaceuticals, Inc (MRNS) in Q4 2024, closing a stake of 19,725 shares — an estimated $34.7K sold.

Two Sigma Advisers first reported a position in MRNS in Q4 2018 and held it in 17 quarters. The position peaked at $1.77M in Q1 2021. 53 funds tracked by Wall St. Rank hold MRNS as of Q4 2024.

  • Two Sigma Advisers reported no remaining Marinus Pharmaceuticals, Inc position as of Q4 2024 after selling out during the quarter.
  • Two Sigma Advisers sold 19,725 Marinus Pharmaceuticals, Inc shares in Q4 2024, an estimated $34.7K.
  • Two Sigma Advisers first reported a position in Marinus Pharmaceuticals, Inc in Q4 2018 and held it in 17 quarters.
  • Two Sigma Advisers's Marinus Pharmaceuticals, Inc position peaked at $1.77M in Q1 2021.
  • 53 funds tracked by Wall St. Rank held Marinus Pharmaceuticals, Inc as of Q4 2024.

Based on Two Sigma Advisers's 13F filing for Q4 2024, filed 14 Feb 2025.